Responses
Regular and Young Investigator Award Abstracts
Combination Immunotherapies
805 Oncolytic adenovirus encoding human interleukin-7 in combination with ICIs as a treatment strategy against renal cell carcinoma (RCC)
Compose a Response to This Article
Other responses
No responses have been published for this article.